Literature DB >> 12633133

Ziprasidone augmentation of clozapine in 11 patients.

Neil S Kaye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633133     DOI: 10.4088/jcp.v64n0215b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  8 in total

1.  Aripiprazole augmentation of clozapine: in refractory schizophrenia.

Authors:  Adam Keller Ashton
Journal:  Psychiatry (Edgmont)       Date:  2005-02

Review 2.  Benefits and risks of antipsychotic polypharmacy: an evidence-based review of the literature.

Authors:  Constantin Tranulis; Leila Skalli; Pierre Lalonde; Luc Nicole; Emmanuel Stip
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Augmentation strategies in clozapine-resistant schizophrenia.

Authors:  Gary Remington; Amitabha Saha; Siow-Ann Chong; Chekkera Shammi
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  [Augmenting atypical antipsychotic medications with clozapin].

Authors:  M Zink; H Dressing
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

5.  Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.

Authors:  Marc Ziegenbein; Georg Wittmann; Stefan Kropp
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

6.  Clozapine: Current perspective.

Authors:  Ram K Solanki; Paramjeet Singh; Mukesh K Swami
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

7.  Current perspectives in the treatment of resistant schizophrenia.

Authors:  R K Solanki; Paramjeet Singh; Deepti Munshi
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

8.  Ziprasidone as adjunctive therapy in severe bipolar patients treated with clozapine.

Authors:  Natalia Bartolommei; Francesco Casamassima; Laura Pensabene; Federica Luchini; Antonella Benvenuti; Antonello Di Paolo; Luca Cosentino; Mauro Mauri; Lorenzo Lattanzi
Journal:  ISRN Psychiatry       Date:  2014-04-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.